The Pilot Project Program (PPP) for the Center for Evolutionary and Theoretical Immunology (CETI) was established in Phase II of CETI's existence. This program, which has proven to be popular in these difficult funding times, is designed to enable investigators to collect data needed to increase the competitiveness of their grants for funding. In so doing, it helps CETI to achieve one of the major goals of the IDeA program, namely to increase our critical mass of funded investigators. The PPP we propose for Phase III has three major goals. The first is to facilitate maintenance of the PPP into Phase III and beyond. We intend to award each successful applicant an amount of $25-50K per annum with the possibility of continued funding into a second year. Because of the need to purchase equipment for our scientific cores, our PPP will be relatively small in years one and two but will be expanded to the full allowable amount in years three through five. Additionally, support received from the UNM administration will provide another $200K to continue our PPP in the five years following Phase III. The second goal of the PPP is to assist our three scientific cores in transitioning to independence from COBRE funding. Beginning in year three, we will begin a phased reduction of COBRE support for each of our three cores. By year five, the cores will be cost neutral. However, funds coming into each core from PPP recipients will help each core achieve cost neutrality. In addition, both our PPP and our waiver program will have the benefit of increasing the user base for each of our scientific cores. A third goal of our PPP is to provide both training for all equipment items used by recipients in our cores, and the mentoring services provided by our Administrative Core. Training will allow recipients to take full advantage of the instrumentation and services in our Cores. Mentoring will emphasize production of more competitive research proposals and favor the long-term academic success of our recipients. Additionally and importantly, PPP recipients will be offered the benefit of using CETI's wellestablished grant preparation and submission portal, thereby greatly facilitating what can be a difficult and demanding process. Finally, all PP recipients will be encouraged to participate in all CETI's programmatic activities, including lunches, seminars, and meetings. The PPP is a vital part of CETI as it increases our core user base and the competitiveness of our investigators, and helps us realize the long-term goals of both CETI and the IDeA program.

Public Health Relevance

In these difficult funding times, the Pilot Project Program overseen by the Administrative Core of the Center for Evolutionary and Theoretical Immunology (CETI) provides much needed funds for investigators, especially beginning investigators, to collect preliminary data needed to support successful full-scale extramural research proposals. By favoring the long-term success of New Mexico scientists, CETI helps improve the economic outlook and scientific competitiveness of our state, in line with the goals of the IDeA program.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1-TWD-C (3C))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of New Mexico
United States
Zip Code
Dahari, Harel; Cotler, Scot J; Feld, Jordan J (2016) Cure prevents more than transmission of HCV. Hepatology :
Canini, Laetitia; Guedj, Jeremie; Chatterjee, Anushree et al. (2016) Modelling the interaction between danoprevir and mericitabine in the treatment of chronic HCV infection. Antivir Ther 21:297-306
Krasnec, Katina V; Papenfuss, Anthony T; Miller, Robert D (2016) The UT family of MHC class I loci unique to non-eutherian mammals has limited polymorphism and tissue specific patterns of expression in the opossum. BMC Immunol 17:43
McLean, Nancy Johnstone; Newkirk, Kimberly; Adema, Coenraad M (2016) Canine ocular onchocerciasis: a retrospective review of the diagnosis, treatment, and outcome of 16 cases in New Mexico (2011-2015). Vet Ophthalmol :
Tavalire, Hannah F; Blouin, Michael S; Steinauer, Michelle L (2016) Genotypic variation in host response to infection affects parasite reproductive rate. Int J Parasitol 46:123-31
Larragoite, Erin T; Tacchi, Luca; LaPatra, Scott E et al. (2016) An attenuated virus vaccine appears safe to the central nervous system of rainbow trout (Oncorhynchus mykiss) after intranasal delivery. Fish Shellfish Immunol 49:351-4
Zhang, Si-Ming; Loker, Eric S; Sullivan, John T (2016) Pathogen-associated molecular patterns activate expression of genes involved in cell proliferation, immunity and detoxification in the amebocyte-producing organ of the snail Biomphalaria glabrata. Dev Comp Immunol 56:25-36
Lu, Lijun; Zhang, Si-Ming; Mutuku, Martin W et al. (2016) Relative compatibility of Schistosoma mansoni with Biomphalaria sudanica and B. pfeifferi from Kenya as assessed by PCR amplification of the S. mansoni ND5 gene in conjunction with traditional methods. Parasit Vectors 9:166
Elwell, Jennifer A; Lovato, TyAnna L; Adams, Melanie M et al. (2015) The myogenic repressor gene Holes in muscles is a direct transcriptional target of Twist and Tinman in the Drosophila embryonic mesoderm. Dev Biol 400:266-76
Zhang, Si-Ming; Buddenborg, Sarah K; Adema, Coen M et al. (2015) Altered Gene Expression in the Schistosome-Transmitting Snail Biomphalaria glabrata following Exposure to Niclosamide, the Active Ingredient in the Widely Used Molluscicide Bayluscide. PLoS Negl Trop Dis 9:e0004131

Showing the most recent 10 out of 48 publications